Articles

Dexamethasone (6 mg/m2/day) and prednisolone (60 mg/m2/day) were equally effective as induction therapy for childhood acute lymphoblastic leukemia in the EORTC CLG 58951 randomized trial

Institute of Hematology and Oncology Pediatrics, Hospices Civils de Lyon, University Claude Bernard Lyon I, France
EORTC Headquarters, Brussels, Belgium
Department of Pediatric Hematology-Oncology, Ghent University Hospital, Belgium
Department of Pediatric Hematology-Oncology, CHR, Lille, France
Department of Hematology, Children’s Hospital, Toulouse, France
Department of Pediatrics, University Hospital Gasthuisberg, Leuven, Belgium
Department of Hemato-Oncology, HUDERF Brussels, Belgium
Department of Hemato-Oncology, A Villeneuve Hospital, Montpellier, France
Department of Hematology, Hautepierre, Strasbourg, France
Department of Hematology, Robert Debré Hospital, Paris, France
Department of Hematology, American Hospital, Reims, France
Department of Hemato-Oncology, CHRU, Besançon, France
Department of Pediatrics, CHR La Tronche, Grenoble, France
Department of Hematology, J Bernard Hospital, Poitiers, France
Department of Pediatrics, CHC-Esperance, Montegnée, Belgium
Department of Hematology, Children’s Hospital, Toulouse, France
Department of Hematology, Edouard Herriot Hospital, Hospices Civils de Lyon, France
Department of Genetics, Robert-Debré Hospital, Paris, France
Department of Pediatric Hematology-Oncology, Ghent University Hospital, Belgium
Institute of Hematology and Oncology Pediatrics, Hospices Civils de Lyon, University Claude Bernard Lyon I, France
Vol. 99 No. 7 (2014): July, 2014 https://doi.org/10.3324/haematol.2014.103507